Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

2.

Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.

Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, Seipone K, Makhema MJ, Marlink RG, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):365-72. doi: 10.1089/aid.2010.0273.

PMID:
21034246
3.
4.

[AIDS treatment in Africa: the risk of antiretroviral resistance].

Hamers RL, Schuurman R, van Vugt M, Derdelinckx I, Rinke de Wit TF.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2666-71. Review. Dutch.

PMID:
18179083
5.

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

Hance AJ, Lemiale V, Izopet J, Lecossier D, Joly V, Massip P, Mammano F, Descamps D, Brun-Vézinet F, Clavel F.

J Virol. 2001 Jul;75(14):6410-7.

7.

What can modeling tell us about the threat of antiviral drug resistance?

Blower S, Volberding P.

Curr Opin Infect Dis. 2002 Dec;15(6):609-14. Review.

PMID:
12821838
8.

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.

Booth CL, Geretti AM.

J Antimicrob Chemother. 2007 Jun;59(6):1047-56. Review.

9.

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.

Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V; Red de Investigación en SIDA..

J Med Virol. 2005 Sep;77(1):23-8.

PMID:
16032728
10.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

Yerly S, von Wyl V, Ledergerber B, Böni J, Schüpbach J, Bürgisser P, Klimkait T, Rickenbach M, Kaiser L, Günthard HF, Perrin L; Swiss HIV Cohort Study..

AIDS. 2007 Oct 18;21(16):2223-9.

PMID:
18090050
11.

Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance.

Blower S, Ma L, Farmer P, Koenig S.

Curr Drug Targets Infect Disord. 2003 Dec;3(4):345-53. Review.

PMID:
14754434
12.

Transmission of HIV-1 drug resistance.

Tang JW, Pillay D.

J Clin Virol. 2004 May;30(1):1-10. Review.

PMID:
15072747
13.

AIDS in the Third World: how to stop the HIV infection?

De Clercq E.

Verh K Acad Geneeskd Belg. 2007;69(2):65-80. Review.

PMID:
17550059
14.

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.

Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF.

Antivir Ther. 2008;13 Suppl 2:25-36.

PMID:
18575189
15.

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).

Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, Mask CW, Sierra EM, Vallejo R, Page JB, Klimas NG, Fletcher MA.

J Environ Pathol Toxicol Oncol. 2003;22(3):201-34. Review.

PMID:
14529094
16.

Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.

van de Vijver DA, Derdelinckx I, Boucher CA.

J Infect Dis. 2009 May 1;199(9):1310-7. doi: 10.1086/597804.

17.

Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.

Maphalala G, Okello V, Mndzebele S, Gwebu P, Mulima N, Dlamini S, Nhlabatsi B, Ginindza T, Ghebrenegus Y, Ntilivamunda A, Mwanyumba F, Ledwaba J, Pillay V, Bennett DE.

Antivir Ther. 2008;13 Suppl 2:95-100.

PMID:
18575197
18.

Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons.

García-Lerma JG.

J Antimicrob Chemother. 2005 Aug;56(2):265-9. Review.

19.

Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.

Capiluppi B, Saracco A, Gianotti N, Mussini C, Butini L, Tomasoni L, De Gennaro M, Rizzolo L, Monolo G, Cargnel A, Moioli C, Arici C, Portelli V, Rizzardini G, Lazzarin A, Tambussi G.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):73-8.

PMID:
12003179
20.

Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000.

Scott P, Arnold E, Evans B, Pozniak A, Moyle G, Shahmenesh M, White D, Shirley J, Cane P, Pillay D.

J Antimicrob Chemother. 2004 Mar;53(3):469-73.

Items per page

Supplemental Content

Support Center